`

Recbio

Biotechnology

Specialities :
Vaccine
Adjuvant
Hpv vaccine
And covid19 vaccine
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$156.28M
size-icon Size
11 - 50

Frequently Asked Questions About Recbio

What does Recbio do?+

Recbio(HKEX:02179) is an innovative vaccine company founded in 2012. With the vision of Become the Leader of Innovative Vaccine in the Future, Recbio takes Protect Human Health with Best-in-Class Vaccines as its mission. It has established three major cutting-edge technology platforms including novel adjuvants platform, protein engineering platform, and immunological evaluation platform. Recbio has a high-value vaccine portfolio consisted of recombinant protein, HPV vaccine candidates, COVID-19 vaccine candidates, shingles vaccine candidates, influenza vaccine candidates, adults TB vaccine candidates, etc. The core scientific team has more than 20 years of experience in the development and commercialization of innovative vaccines. For more...

What are Recbio's specialties? +

Vaccine,adjuvant,hpv vaccine,and covid19 vaccine

What is Recbio's industry? +

Recbio operates in the Biotechnology industry.

What is Recbio's revenue? +

Recbio's revenue is 11m - 100m

What is Recbio's company size? +

Recbio has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.